File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Chylothorax in Children After Congenital Heart Surgery

TitleChylothorax in Children After Congenital Heart Surgery
Authors
Issue Date2006
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/athoracsur
Citation
Annals Of Thoracic Surgery, 2006, v. 82 n. 5, p. 1650-1656 How to Cite?
Abstract
Background: A definitive management strategy for postoperative chylothorax remains elusive. We reviewed our experience in the management of chylothorax in children after congenital heart surgery. Methods: The case records of 51 patients, with a median age of 11 months (range, 4 days to 19.6 years), diagnosed to have postoperative chylothorax between 1981 and 2004 were reviewed. The responses of patients to nutritional modifications, octreotide therapy, and surgical interventions were noted. Results: The prevalence of postoperative chylothorax, which developed at a median of 9 days after operation (range, 0 to 24 days), was 0.85% (51 of 5,995). Four patients died, and among the 47 survivors the median duration and total volume of chylous drainage was 15 days (range, 1 to 89 days) and 156 mL/kg (range, 3 to 6,476), respectively. The duration of chyle output was significantly longer after the Fontan-type procedures (p = 0.0006). Twenty-one patients were diagnosed between 1981 and 1999 and managed by nutritional modifications, 2 of whom required further surgical interventions. Of the 30 patients diagnosed between 2000 and 2004, 12 responded to nutritional modifications alone while 18 were started on octreotide therapy at a median of 19.5 days (range, 7 to 35 days) after the onset of chylothorax. Fifteen of the 18 (83%) patients responded to octreotide therapy at 15.3 ± 5.5 days after starting octreotide, while 3 required further surgical interventions. None developed side effects from octreotide therapy. Conclusions: Octreotide has been incorporated into the management algorithm of postoperative chylothorax and appears to be a useful adjunctive therapy. © 2006 The Society of Thoracic Surgeons.
Persistent Identifierhttp://hdl.handle.net/10722/170379
ISSN
2013 Impact Factor: 3.631
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorChan, Syen_US
dc.contributor.authorLau, Wen_US
dc.contributor.authorWong, WHSen_US
dc.contributor.authorCheng, Lcen_US
dc.contributor.authorChau, AKTen_US
dc.contributor.authorCheung, Yfen_US
dc.date.accessioned2012-10-30T06:07:54Z-
dc.date.available2012-10-30T06:07:54Z-
dc.date.issued2006en_US
dc.identifier.citationAnnals Of Thoracic Surgery, 2006, v. 82 n. 5, p. 1650-1656en_US
dc.identifier.issn0003-4975en_US
dc.identifier.urihttp://hdl.handle.net/10722/170379-
dc.description.abstractBackground: A definitive management strategy for postoperative chylothorax remains elusive. We reviewed our experience in the management of chylothorax in children after congenital heart surgery. Methods: The case records of 51 patients, with a median age of 11 months (range, 4 days to 19.6 years), diagnosed to have postoperative chylothorax between 1981 and 2004 were reviewed. The responses of patients to nutritional modifications, octreotide therapy, and surgical interventions were noted. Results: The prevalence of postoperative chylothorax, which developed at a median of 9 days after operation (range, 0 to 24 days), was 0.85% (51 of 5,995). Four patients died, and among the 47 survivors the median duration and total volume of chylous drainage was 15 days (range, 1 to 89 days) and 156 mL/kg (range, 3 to 6,476), respectively. The duration of chyle output was significantly longer after the Fontan-type procedures (p = 0.0006). Twenty-one patients were diagnosed between 1981 and 1999 and managed by nutritional modifications, 2 of whom required further surgical interventions. Of the 30 patients diagnosed between 2000 and 2004, 12 responded to nutritional modifications alone while 18 were started on octreotide therapy at a median of 19.5 days (range, 7 to 35 days) after the onset of chylothorax. Fifteen of the 18 (83%) patients responded to octreotide therapy at 15.3 ± 5.5 days after starting octreotide, while 3 required further surgical interventions. None developed side effects from octreotide therapy. Conclusions: Octreotide has been incorporated into the management algorithm of postoperative chylothorax and appears to be a useful adjunctive therapy. © 2006 The Society of Thoracic Surgeons.en_US
dc.languageengen_US
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/athoracsuren_US
dc.relation.ispartofAnnals of Thoracic Surgeryen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshCardiac Surgical Procedures - Adverse Effectsen_US
dc.subject.meshChilden_US
dc.subject.meshChild, Preschoolen_US
dc.subject.meshChylothorax - Etiology - Therapyen_US
dc.subject.meshDiet Therapyen_US
dc.subject.meshFemaleen_US
dc.subject.meshGastrointestinal Agents - Therapeutic Useen_US
dc.subject.meshHeart Defects, Congenital - Surgeryen_US
dc.subject.meshHumansen_US
dc.subject.meshInfanten_US
dc.subject.meshInfant, Newbornen_US
dc.subject.meshMaleen_US
dc.subject.meshOctreotide - Therapeutic Useen_US
dc.subject.meshTriglycerides - Therapeutic Useen_US
dc.titleChylothorax in Children After Congenital Heart Surgeryen_US
dc.typeArticleen_US
dc.identifier.emailCheung, Yf:xfcheung@hku.hken_US
dc.identifier.authorityCheung, Yf=rp00382en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1016/j.athoracsur.2006.05.116en_US
dc.identifier.pmid17062221en_US
dc.identifier.scopuseid_2-s2.0-33750063968en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-33750063968&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume82en_US
dc.identifier.issue5en_US
dc.identifier.spage1650en_US
dc.identifier.epage1656en_US
dc.identifier.isiWOS:000241497600011-
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridChan, Sy=7404255845en_US
dc.identifier.scopusauthoridLau, W=7402933338en_US
dc.identifier.scopusauthoridWong, WHS=13310222200en_US
dc.identifier.scopusauthoridCheng, Lc=9533935800en_US
dc.identifier.scopusauthoridChau, AKT=35787094400en_US
dc.identifier.scopusauthoridCheung, Yf=7202111067en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats